← brief for 2026-09-04 · Slowing decline

Gli inibitori di SGLT2 nel diabete di tipo 1: è tempo di rivalutarne il ruolo

Paper No results yet Peer reviewed

Key takeaways

This Italian-language article argues it is time to reconsider SGLT2 inhibitors for people with type 1 diabetes. These drugs clearly protect the kidneys in type 2 diabetes, but in type 1 they raise the risk of a dangerous acid build-up in the blood. The piece weighs that trade-off and calls for a fresh look. It reports no new results.

Who did this work

Andrea Giaccari

Source

Paper · OpenAlex, CKD works · 2026-09-03
https://doi.org/10.30682/ildia2602c